DONNA DRAPER: Open Payments
NPI 1912212358 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,648 in 187 payments from 21 companies in 2025. Trend: 2023 $3,217 · 2024 $4,203 · 2025 $4,648
Food & beverage: $4,531Education: $117
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $714 |
| ABBVIE INC. | 44 | $685 |
| Teva Pharmaceuticals USA, Inc. | 16 | $669 |
| Otsuka America Pharmaceutical, Inc. | 27 | $417 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $323 |
| Janssen Pharmaceuticals, Inc | 11 | $267 |
| Corium, LLC | 14 | $258 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $209 |
| Vanda Pharmaceuticals Inc. | 8 | $192 |
| Axsome Therapeutics, Inc. | 8 | $189 |
Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, REXULTI, CAPLYTA, UZEDY, Azstarys, REJOYN.
Industry payments across CT — which companies pay providers there.
